×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
四川大学 [3]
复旦大学上海医学院 [3]
中国医学科学院 北京... [2]
西安交通大学 [1]
上海药物研究所 [1]
山东大学 [1]
更多...
内容类型
期刊论文 [14]
发表日期
2019 [1]
2018 [1]
2015 [3]
2013 [1]
2012 [1]
2011 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共14条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 50
作者:
Liao Jun-Fang
;
Zhang Qun
;
Du Xiao-Jing
;
Lan Mei
;
Liu Shan
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/01/03
Concurrent chemoradiotherapy with weekly docetaxel and cisplatin versus docetaxel and nedaplatin for locally advanced esophageal carcinoma
期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 卷号: 11, 期号: 8, 页码: 8382-8391
作者:
Lu, Chunhui
;
Liang, Ning
;
Hu, Pingping
;
Zhang, Jiandong
;
Zhang, Xuede
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/11
Esophageal squamous cell carcinoma
chemoradiotherapy
intensity-modulated radiotherapy
nedaplatin
locally advanced
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer
期刊论文
PLOS ONE, 2015, 页码: 2015
作者:
Tie Zhou
;
Shu-xiong Zeng
;
Ding-wei Ye
;
Qiang Wei
;
Xu Zhang
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/02/25
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer
期刊论文
PLOS ONE, 2015, 卷号: 10, 期号: 1
作者:
Zhou, Tie
;
Zeng, Shu-xiong
;
Ye, Ding-wei
;
Wei, Qiang
;
Zhang, Xu
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer
期刊论文
2015, 卷号: 10, 期号: 1, 页码: e0117002
作者:
Zhou, Tie
;
Zeng, Shu-xiong
;
Ye, Ding-wei
;
Wei, Qiang
;
Zhang, Xu
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/13
Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison
期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2013, 卷号: 15, 期号: [db:dc_citation_issue], 页码: 773-779
作者:
Li, Yun-Fei
;
Zhang, Shao-Feng
;
Zhang, Tao-Tao
;
Li, Lei
;
Gan, Wei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/10
androgen
chemotherapy
prostate cancer
docetaxel
safety
Effective treatment of esophageal carcinomas using intensity-modulated radiotherapy in combination with nedaplatin and docetaxel
期刊论文
ONCOLOGY LETTERS, 2012, 卷号: 4, 期号: 2
作者:
Chen, Wenjun
;
Wang, Jianhua
;
Zhao, Kuaile
;
Yuan, Shaofei
;
Wang, Yubin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/19
esophageal carcinoma
intensity-modulated radiotherapy
weekly dose of chemotherapy
nedaplatin
docetaxel
Solid lipid nanoparticles reduce systemic toxicity of docetaxel: Performance and mechanism in animal
期刊论文
NANOTOXICOLOGY, 2011, 卷号: 5, 期号: 4, 页码: 636-649
作者:
Gao, Yu
;
Yang, Rongfu
;
Zhang, Zhiwen
;
Chen, Lingli
;
Sun, Zuyue
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/01/08
Nanotoxicity
nanoparticles
docetaxel
nanomedicine
toxicity
Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer
期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123, 期号: 22
作者:
Wang Hua-qing
;
Qian Zheng-zi
;
Liu Xian-ming
;
Zhang Hui-lai
;
Li Lan-fang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
capecitabine
weekly docetaxel
metastatic breast cancer
anthracycline
elderly
tolerability
Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer
期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123
-
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/10/26
PHASE-III TRIAL
PLUS DOCETAXEL
MULTICENTER
THERAPY
PHOSPHORYLASE
TOLERABILITY
PACLITAXEL
XELODA(R)
SURVIVAL
capecitabine
weekly docetaxel
metastatic breast cancer
anthracycline
elderly
tolerability
©版权所有 ©2017 CSpace - Powered by
CSpace